Loading Events

« All Events

  • This event has passed.

Superbugs & Superdrugs USA

November 12, 2018 - November 13, 2018

SMi Group's Superbugs & Superdrugs USA 2018

The 2018 Superbugs & Superdrugs USA conference will be held 12-13 November 2018 in Iselin, New Jersey.

This 3rd annual Superbugs & Superdrugs USA conference will help participants to learn about pathogen focused drug development; discover the best methods to overcome bacterial resistance through novel modes of action; discuss the state of developments within the antifungal space; develop an understanding of funding opportunities which support antibacterial research and development; gain insight into new techniques through case-study examples of rapid diagnostic methods currently being used within the field, making this event the perfect platform to strengthen knowledge in key principles.

Speakers include:

  • Anthony Simon Lynch, Senior Scientific Director, Janssen
  • William Weiss, Director, Pre-Clinical Services, UNT Health Science Center
  • Tina Guina, Program Officer, Drug Development Section, NIAID/NIH
  • Mark Albrecht, Project Officer, HHS/ASPR/BARDA
  • Antonio DiGiandomenico, Principal Scientist, MedImmune
  • Andrew Tomaras, VP & Director of Microbiology, Bacterioscan
  • Dan Pevear, Sr Vice President & Director of Microbiology, VenatoRx
  • Ian Friedland, Clinical Consultant, ex-CMO, Achaogen

Highlighted session topics include:

  • Rapid Diagnostics for Drug Resistance: Are We There Yet?
  • NIAID Funding and Resources for Development of Anti-Infectives
  • Overcoming Bacterial Resistance Through A Novel Mode of Action
  • Avoiding the Post Antibiotic Era: The Challenges and Solutions to Successful Commercialization of New Antibiotics
  • Epidemiology, Resistance and Treatments of GI Related Infectious Disease
  • Practical Clinical Diagnostic Applications Using Laser Light-Scattering: Utility, Adoption, And Opportunities
  • Supporting Antibacterial Research and Development
  • Discovery and Evaluation of Inhibitors of Intermediary Metabolism as Novel Antibiotics Against Gram-Negative Bacterial Pathogens
  • CMC Strategies for Novel Antibiotic Drug Development
  • Pathogen-Focused Drug Development: Buyer Beware
  • VNRX-5133: A Highly Potent and Broad-Spectrum Inhibitor of Both Serine and Metallo Beta-Lactamases
  • A Novel Fluorocycline Antibiotic with Potent Activity Against Carbapenem-Resistant Gram (-) Organisms

Please visit the event website for further details or contact Luda Durneva: +44 (0)20 7827 6000

Stay up to date by following SMi on Twitter @SMIpharm #smibugs and LinkedIn SMi Pharma.

Global Biodefense is an official media partner of Superbugs & Superdrugs 2018.


November 12, 2018
November 13, 2018
Event Category:
Event Tags:
, , , , , ,


SMi Group
+44 (0) 20 7827 6000
View Organizer Website


Renaissance Woodbridge Hotel
515 US-1
Iselin, NJ 08830 United States
(732) 634-3600
View Venue Website